Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126013381 | 12601338 | 1 | I | 201605 | 20160713 | 20160728 | 20160728 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120927 | RANBAXY | 71.00 | YR | F | Y | 61.68000 | KG | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126013381 | 12601338 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | INITIAL DOSE 30MG FOR 1 MONTH THEN MAINTAINENCE DOSE OF 15MG DAILY | N | U | 202637 | 15 | MG | ||||||
| 126013381 | 12601338 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | INITIAL DOSE 30MG FOR 1 MONTH THEN MAINTAINENCE DOSE OF 15MG DAILY | U | LC26449 | 0 | 30 | MG | ||||||
| 126013381 | 12601338 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | U | U | 0 | 75 | MG | |||||||
| 126013381 | 12601338 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | U | 0 | 40 | MG | |||||||
| 126013381 | 12601338 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | U | 0 | 2.5 | MG | |||||||
| 126013381 | 12601338 | 6 | C | FLAX SEED | FLAX SEED | 1 | Unknown | U | U | 0 | |||||||||
| 126013381 | 12601338 | 7 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | Unknown | U | U | 0 | 1000 | MG | |||||||
| 126013381 | 12601338 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | U | U | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126013381 | 12601338 | 1 | Product used for unknown indication |
| 126013381 | 12601338 | 2 | Product used for unknown indication |
| 126013381 | 12601338 | 3 | Product used for unknown indication |
| 126013381 | 12601338 | 4 | Product used for unknown indication |
| 126013381 | 12601338 | 5 | Product used for unknown indication |
| 126013381 | 12601338 | 6 | Product used for unknown indication |
| 126013381 | 12601338 | 7 | Product used for unknown indication |
| 126013381 | 12601338 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126013381 | 12601338 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126013381 | 12601338 | Abdominal distension | |
| 126013381 | 12601338 | Abnormal loss of weight | |
| 126013381 | 12601338 | Diarrhoea | |
| 126013381 | 12601338 | Gastrointestinal sounds abnormal | |
| 126013381 | 12601338 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126013381 | 12601338 | 1 | 201603 | 201606 | 0 | |
| 126013381 | 12601338 | 2 | 201602 | 201603 | 0 |